Akustička procjena i samoprocjena glasa osoba s Parkinsonovom bolesti = Acoustic and self-assessment of voice in Parkinson's diseasePUSIC, Maja; BONETTI, Ana; VULETIC, Vladimira et al.Govor (Zagreb). 2013, Vol 30, Num 2, pp 103-115, issn 0352-7565, 13 p.Article

Clinical characteristics of headache in Parkinsońs diseaseINDO, T; NAITO, A; SOBUE, I et al.Headache. 1983, Vol 23, Num 5, pp 211-212, issn 0017-8748Article

Parkinsonian deficits in serial multiarticulate movements for speechCONNOR, N. P; ABBS, J. H; COLE, K. J et al.Brain. 1989, Vol 112, Num 4, pp 997-1009, issn 0006-8950, 13 p.Article

Epidemiology of Parkinson's disease in a Japanese CityHARADA, H; NISHIKAWA, S; TAKAHASHI, K et al.Archives of neurology (Chicago). 1983, Vol 40, Num 3, pp 151-154, issn 0003-9942Article

Dementia in Parkinson's diseaseCanadian journal of neurological sciences. 1984, Vol 11, Num 1, pp 180-190, issn 0317-1671Article

Unified Parkinson's disease rating scale characteristics and structureMARTINEZ-MARTIN, P; GIL-NAGEL, A; MORLAN GRACIA, L et al.Movement disorders. 1994, Vol 9, Num 1, pp 76-83, issn 0885-3185Article

Fully automated assessment of the severity of Parkinson's disease from speech : Next Generation Computational ParalinguisticsBAYESTEHTASHK, Alireza; ASGARI, Meysam; SHAFRAN, Izhak et al.Computer speech & language (Print). 2015, Vol 29, Num 1, pp 172-185, issn 0885-2308, 14 p.Article

Final lengthening in Parkinsonian French Speech: Effects of position in phrase on the duration of CV syllables and speech segmentsDUEZ, Danielle; LEGOU, Thierry; VIALLET, François et al.Clinical linguistics & phonetics. 2009, Vol 23, Num 11, pp 781-793, issn 0269-9206, 13 p.Article

Neuropathologie des syndromes parkinsoniens = Neuropathology of ParkinsonismGRAY, F.Revue neurologique (Paris). 1988, Vol 144, Num 4, pp 229-248, issn 0035-3787Article

The heterogeneity of Parkinson's disease: clinical and prognostic implicationsZETUSKY, W. J; JANKOVIC, J; PIROZZOLO, F. J et al.Neurology. 1985, Vol 35, Num 4, pp 522-526, issn 0028-3878Article

Alpha- and beta-synuclein expression in Parkinson disease with and without dementiaBEYER, Katrin; ISPIERTO, Lourdes; LATORRE, Pilar et al.Journal of the neurological sciences. 2011, Vol 310, Num 1-2, pp 112-117, issn 0022-510X, 6 p.Article

Toward a definition of Parkinson's diseaseDUVOISIN, R. C; GOLBE, L. I.Neurology. 1989, Vol 39, Num 5, issn 0028-3878, 746Article

Encephalitis lethargica: a report of four recent casesHOWARD, R. S; LEES, A. J.Brain. 1987, Vol 110, Num 1, pp 19-33, issn 0006-8950Article

Long-term study of pergolide in Parkinson's diseaseJANKOVIC, J.Neurology. 1985, Vol 35, Num 3, pp 296-299, issn 0028-3878Article

Aspects cliniques et thérapeutiques des syndromes parkinsoniens débutant après 70 ans. A propos d'une série de 34 observations = Parkinsonism: onset after 70 years old, clinical and therapeutic aspects. A study of 34 casesSTRUBEL, D; RIETSCH, M. P; KUNTZMANN, F et al.Médecine et hygiène. 1984, Vol 42, Num 1564, pp 1670-1676, issn 0025-6749Article

The possible relation of glutathione, melanin and 1-methyl-4-phenyl-1,2,5,6-tetra-hydropyridine (MPTP) to Parkinson's diseaseBANNON, M. J; GOEDERT, M; WILLIAMS, B et al.Biochemical pharmacology. 1984, Vol 33, Num 17, pp 2697-2698, issn 0006-2952Article

Chronic levodopa or pergolide administration induced down-regulation of dopamine receptors in denervated striatumRECHES, A; WAGNER, H. R; JACKSON-LEWIS, V et al.Neurology. 1984, Vol 34, Num 9, pp 1208-1212, issn 0028-3878Article

Sensory symptoms in Parkinson's diseaseKOLLER, W. C.Neurology. 1984, Vol 34, Num 7, pp 957-959, issn 0028-3878Article

Comparison of pergolide and bromocriptine therapy in parkinsonismLEWITT, P. A; WARD, C. D; LARSEN, T. A et al.Neurology. 1983, Vol 33, Num 8, pp 1009-1014, issn 0028-3878Article

Evaluating the evaluations: or how to weigh the scales of parkinsonian disabilityDIAMOND, S. G; MARKHAM, C. H.Neurology. 1983, Vol 33, Num 8, pp 1098-1099, issn 0028-3878Article

Neurological assessmentBYER, J. A; DEXTER, J. D.Brain research bulletin. 1983, Vol 11, Num 2, pp 143-147, issn 0361-9230Article

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (dopamine/homovanillic acid/5-hydroxyindoleacetic/3-methoxy-4-hydroxyphenylethylene glycol)BURNS, R. S; CHIUEH, C. C; MARKEY, S. P et al.Proceedings of the National Academy of Sciences of the United States of America. Biological sciences. 1983, Vol 80, Num 14, pp 4546-4550, issn 0273-1134Article

Lack of association between essential tremor and Parkinson's diseaseCLEEVES, L; FINDLEY, L. J; KOLLER, W et al.Annals of neurology. 1988, Vol 24, Num 1, pp 23-26, issn 0364-5134Article

Genetic factors and epidemiology of Parkinson's diseaseCanadian journal of neurological sciences. 1984, Vol 11, Num 1, pp 144-159, issn 0317-1671Article

Toxic environmental factors causing ParkinsonismCanadian journal of neurological sciences. 1984, Vol 11, Num 1, pp 160-168, issn 0317-1671Article